Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
XN Shen, LD Niu, YJ Wang, XP Cao, Q Liu… - Journal of Neurology …, 2019 - jnnp.bmj.com
Objective Inflammation plays a crucial role in the pathogenesis of mild cognitive impairment
(MCI) and Alzheimer's disease (AD). Our study aimed to analyse previous inconsistent …
(MCI) and Alzheimer's disease (AD). Our study aimed to analyse previous inconsistent …
A walk through tau therapeutic strategies
S Jadhav, J Avila, M Schöll, GG Kovacs… - Acta neuropathologica …, 2019 - Springer
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …
and related human tauopathies. There is a growing body of evidence indicating that …
A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease
Some forms of mild cognitive impairment (MCI) are the clinical precursors of Alzheimer's
disease (AD), while other MCI types tend to remain stable over-time and do not progress to …
disease (AD), while other MCI types tend to remain stable over-time and do not progress to …
A CNN based framework for classification of Alzheimer's disease
In the current decade, advances in health care are attracting widespread interest due to their
contributions to people longer surviving and fitter lives. Alzheimer's disease (AD) is the …
contributions to people longer surviving and fitter lives. Alzheimer's disease (AD) is the …
[HTML][HTML] The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis …
Introduction A systematic review and meta-analysis was performed regarding the diagnostic
performance of neurofilament light chain (NfL) in CSF and blood. Methods A database …
performance of neurofilament light chain (NfL) in CSF and blood. Methods A database …
Detection of aggregation-competent tau in neuron-derived extracellular vesicles
Progressive cerebral accumulation of tau aggregates is a defining feature of Alzheimer's
disease (AD). A popular theory that seeks to explain the apparent spread of neurofibrillary …
disease (AD). A popular theory that seeks to explain the apparent spread of neurofibrillary …
Potential role of chitinase‐3‐like protein 1 (CHI3L1/YKL‐40) in neurodegeneration and Alzheimer's disease
K Connolly, M Lehoux, R O'Rourke… - Alzheimer's & …, 2023 - Wiley Online Library
Abstract Chitinase‐3‐like protein 1 (CHI3L1/YKL‐40) has long been known as a biomarker
for early detection of neuroinflammation and disease diagnosis of Alzheimer's disease (AD) …
for early detection of neuroinflammation and disease diagnosis of Alzheimer's disease (AD) …
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
Introduction Blood-based biomarkers of pathophysiological brain amyloid β (Aβ)
accumulation, particularly for preclinical target and large-scale interventions, are warranted …
accumulation, particularly for preclinical target and large-scale interventions, are warranted …
[HTML][HTML] Genetic architecture of Alzheimer's disease
Advances in genetic and genomic technologies over the last thirty years have greatly
enhanced our knowledge concerning the genetic architecture of Alzheimer's disease (AD) …
enhanced our knowledge concerning the genetic architecture of Alzheimer's disease (AD) …
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease
Over the past several years, there has been a surge in blood biomarker studies examining
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …